Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Campbell

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|December 18, 2016
The Management of Nausea and Vomiting of PregnancyKim Campbell, Hilary Rowe, Hussam Azzam, et al.
Journal of Pediatric Rehabilitation Medicine|March 12, 2016
Rehabilitative technology use among individuals with Duchenne/Becker muscular dystrophyShree Pandya, Jennifer Andrews, Kim Campbell, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|December 18, 2016
Prise en charge des nausées et vomissements de la grossesseKim Campbell, Hilary Rowe, Hussam Azzam, et al.
Expert Review of Hematology|July 6, 2022
G-CSF primary prophylaxis use and outcomes in patients receiving chemotherapy at intermediate risk for febrile neutropenia: a scoping reviewKim Campbell, Nidhi Chadha, Seema Dimri, et al.
JCO Oncology Practice|May 7, 2021
Economic Analysis on Adoption of Biosimilar Granulocyte Colony-Stimulating Factors in Patients With Nonmyeloid Cancer at Risk of Febrile Neutropenia Within the Oncology Care Model FrameworkWeijia Wang, Edward Li, Kim Campbell, et al.
Journal of the American Association of Nurse Practitioners|January 2, 2026
Unveiling the challenges in diagnosing and managing cardiac amyloidosis: A clinical case reportLydia Peay, Chena Allen, Lashaunda Clerizier, et al.
Journal of Health Economics and Outcomes Research|February 7, 2022
The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data AnalysisEdward Li, Bridgette Kanz Schroader, David Campbell, et al.
Perfusion|October 15, 2024
Accuracy of the HemoCue® to measure cell-free plasma hemoglobin and detect clinically significant hemolysisMadison Butler, Anna Maywar, Kristine Ruppert, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 4, 2026
Development of a Plasma Free Hemoglobin-Adsorbing Device for Extracorporeal TherapiesMadison Butler, Anna Maywar, Ryan Orizondo, et al.
JCO Oncology Practice|April 1, 2021
Primary Prophylaxis With Biosimilar Filgrastim for Patients at Intermediate Risk for Febrile Neutropenia: A Cost-Effectiveness AnalysisEdward Li, Dylan J Mezzio, David Campbell, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|December 18, 2016
The Management of Nausea and Vomiting of PregnancyKim Campbell, Hilary Rowe, Hussam Azzam, et al.
Journal of Pediatric Rehabilitation Medicine|March 12, 2016
Rehabilitative technology use among individuals with Duchenne/Becker muscular dystrophyShree Pandya, Jennifer Andrews, Kim Campbell, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|December 18, 2016
Prise en charge des nausées et vomissements de la grossesseKim Campbell, Hilary Rowe, Hussam Azzam, et al.
Expert Review of Hematology|July 6, 2022
G-CSF primary prophylaxis use and outcomes in patients receiving chemotherapy at intermediate risk for febrile neutropenia: a scoping reviewKim Campbell, Nidhi Chadha, Seema Dimri, et al.
JCO Oncology Practice|May 7, 2021
Economic Analysis on Adoption of Biosimilar Granulocyte Colony-Stimulating Factors in Patients With Nonmyeloid Cancer at Risk of Febrile Neutropenia Within the Oncology Care Model FrameworkWeijia Wang, Edward Li, Kim Campbell, et al.
Journal of the American Association of Nurse Practitioners|January 2, 2026
Unveiling the challenges in diagnosing and managing cardiac amyloidosis: A clinical case reportLydia Peay, Chena Allen, Lashaunda Clerizier, et al.
Journal of Health Economics and Outcomes Research|February 7, 2022
The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data AnalysisEdward Li, Bridgette Kanz Schroader, David Campbell, et al.
Perfusion|October 15, 2024
Accuracy of the HemoCue® to measure cell-free plasma hemoglobin and detect clinically significant hemolysisMadison Butler, Anna Maywar, Kristine Ruppert, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 4, 2026
Development of a Plasma Free Hemoglobin-Adsorbing Device for Extracorporeal TherapiesMadison Butler, Anna Maywar, Ryan Orizondo, et al.
JCO Oncology Practice|April 1, 2021
Primary Prophylaxis With Biosimilar Filgrastim for Patients at Intermediate Risk for Febrile Neutropenia: A Cost-Effectiveness AnalysisEdward Li, Dylan J Mezzio, David Campbell, et al.
Pageof 7